Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Latest News - Dylan Lobo

Stephen Lansdown-backed fund firm launches into UK

Guernsey-based Ravenscroft has launched two of its fund strategies into the UK.

UK inflation falls to 2.6%

The fall in June from May's four-year high of 2.9% came as surprise.

Wealth managers brought into FCA platform market study

The FCA has launched its study into investment platforms, revealing wealth managers are likely to be included as it explores competition in the £500 billion market.

Hermes to stop charging investors for research

The £30 billion fund giant is latest firm to confirm it will stop charging investors for research.

Aristocrat jailed for offering money to kill Gina Miller

The racist aristocrat who offered £5,000 to anyone who would ‘run over’ Brexit campaigner Gina Miller has been sentenced to 12 weeks in jail.

HMRC record £29bn haul as tax avoidance crackdown bites

The tax office's annual report and accounts also showed the tax office collected £574.9 billion in revenue last year.

Ashmore registers $1.2bn quarterly inflow

The net inflow combined with an additional $1.6 billion boost from investment performance lifted assets under management at the EM specialist to $58.7 billion.

Aberdeen appoints head of €57bn Luxembourg office

Aberdeen has hired Julius Baer managing director Steen Foldberg to head an important office in the heart of Europe.

Private bank 'writes history' with Bitcoin offer

Falcon Private Bank's decision to offer clients direct exposure to Bitcoin has been described as a 'game changer' for crypto assets.

Ruffer: we do not regret missing easy gains

The £3.2 billion Ruffer Total Return fund has had a benign first half after a strong 2016 but its management team are not fretting.

Investment Trust video
Play IBT's Craig on the Trump impact for biotech

IBT's Craig on the Trump impact for biotech

Ailsa Craig of the International Biotechnology trust highlights the M&A activity seen in the biotechnology sector this year.

Comment